Alzheimer's Association, Medical & Scientific Relations, Chicago, IL, USA.
Alzheimer's Association, Medical & Scientific Relations, Chicago, IL, USA.
Mol Aspects Med. 2015 Jun-Oct;43-44:16-24. doi: 10.1016/j.mam.2015.06.005. Epub 2015 Jun 18.
In 2012, the first National Plan to Address Alzheimer's Disease in the United States (U.S.) was released, a component of the National Alzheimer's Project Act legislation. Since that time, there have been incremental increases in U.S. federal funding for Alzheimer's disease and related dementia research, particularly in the areas of biomarker discovery, genetic link and related biological underpinnings, and prevention studies for Alzheimer's. A central theme in each of these areas has been the emphasis of cross-sector collaboration and private-public partnerships between government, non-profit organizations and for-profit organizations. This paper will highlight multiple private-public partnerships supporting the advancement of Alzheimer's research in the context of the National Plan to Address Alzheimer's.
2012 年，美国发布了首个《国家阿尔茨海默病计划》，这是《国家阿尔茨海默病项目法案》立法的一部分。从那时起，美国联邦政府对阿尔茨海默病和相关痴呆症研究的资金投入逐渐增加，特别是在生物标志物发现、遗传关联和相关生物学基础以及阿尔茨海默病预防研究等领域。这些领域的一个核心主题是强调政府、非营利组织和营利组织之间跨部门合作和公私伙伴关系。本文将重点介绍多个公私合作伙伴关系，以支持在《国家阿尔茨海默病计划》的背景下推进阿尔茨海默病研究。
